The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


SEMELCEF 200 mg tablets for dogs and cats

200 mg/tablet Tablet

FATRO S.p.A.VPA10836/006/001

Main Information

Trade NameSEMELCEF 200 mg tablets for dogs and cats
Active SubstancesCefadroxil
Strength200 mg/tablet
Dosage FormTablet
Licence HolderFATRO S.p.A.
Licence NumberVPA10836/006/001

Group Information

ATC CodeQJ01DB05 cefadroxil
Therapeutic ClassAntibiotics
SpeciesCats
Dogs

Status

Authorised/WithdrawnAuthorised
Licence Issued28/06/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back